Seattle Flow Your front door to Seattle's startup scene.
Sign in
Stream Events Podcasts Videos Communities
Taylor Soper / GeekWire

Affini-T Therapeutics Closes Seattle Lab, Offering Some Employees Relocation to Boston

Affini-T Therapeutics, a cell therapy company specializing in T cell receptor cancer immunotherapy, is closing its Seattle lab, impacting 17 employees, some of whom may relocate to Boston. The company raised $175 million last year and was spun out of Fred Hutchinson Cancer Research Center.

  • Link
  • Report this item
Replying to

No comments yet.

Seattle Flow — Your front door to Seattle's startup scene.

Run by Marcelo Calbucci MC
Send us a link Terms of Service Privacy For AI assistants
© 2026 Seattle Flow. All rights reserved.

Who liked this

Edit history

Seattle Flow

Your front door to Seattle's startup scene.

Seattle's startup scene is scattered across a hundred feeds, newsletters, and calendars. Seattle Flow brings it together: the news, events, podcasts, and people, plus what the community is saying about them. Every link sends you to the source.

Writing about a Seattle founder, fund, or startup? We'll help it get seen. Found a great story we missed? Send it in.

We're in beta and building this with the community. Tell us what you want to see here.

Seattle's startup scene, every day. The news, events, podcasts, and people, plus what everyone's saying about them. We're in beta: send us a story or tell us what you want to see.